Topical skin care formulations comprising plant extracts
US-2019167560-A1 · Jun 6, 2019 · US
Use of Sida rhombifolia
US12263199B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12263199-B2 |
| Application number | US-202017423078-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 15, 2020 |
| Priority date | Jan 16, 2019 |
| Publication date | Apr 1, 2025 |
| Grant date | Apr 1, 2025 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Proposed is a novel use of Sida rhombifolia , which provides the benefit of effectively treating, ameliorating, inhibiting, and/or preventing benign prostatic hyperplasia.
First claim
Opening claim text (preview).
The invention claimed is: 1. A method of treating, ameliorating, or inhibiting benign prostatic hyperplasia, the method comprising administering an effective amount of Sida rhombifolia to a subject in need thereof, wherein the Sida rhombifolia is prepared as a solvent extract and the treating, the ameliorating, or the inhibiting is achieved by at least one effect selected from inhibition of 5-alpha reductase activity, inhibition of 5-alpha reductase expression, and inhibition of dihydrotestosterone production. 2. The method according to claim 1 , wherein the subject is a non-human animal. 3. The method according to claim 1 , wherein the subject is a human. 4. The method according to claim 1 , the solvent comprises at least one selected from water, ethanol, or a mixture thereof.
Assignees
Inventors
Classifications
- A61K36/577Primary
Malvaceae (Mallow family) · CPC title
- A61P13/08Primary
of the prostate · CPC title
Plant extracts, their artificial duplicates or their derivatives · CPC title
- A61K36/185Primary
Magnoliopsida (dicotyledons) · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US12263199B2 cover?
- Proposed is a novel use of Sida rhombifolia , which provides the benefit of effectively treating, ameliorating, inhibiting, and/or preventing benign prostatic hyperplasia.
- Who is the assignee on this patent?
- Nat Univ Gyeongsang Iacf, Korea Res Inst Bioscience & Biotechnology
- What technology area does this patent fall under?
- Primary CPC classification A61K36/577. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Apr 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).